The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome

Gachon University Gil Medical Center12 enrolled

Overview

Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Eisenmenger's Syndrome

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization Exclusion Criteria:

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.